Increased Investments in R&D Paving Growth Opportunities in the Global Orthopedic Biomaterials Market

Reportstack the leading provider of market research reports, has published a report on the Global Orthopedic Biomaterials Market 2014-2018, which is expected to post a CAGR of 10.78 percent during the forecast period of 2013-2018.

Orthopedic biomaterial deals with the physical and chemical properties of the material that is implanted in the body as constituents of devices. It plays a vital role in the implantation of such devices and provides a beneficial objective for physiological requirements with a complex interplay of the materials properties.

“Orthopedic biomaterials have revolutionized areas such as tissue engineering and bioengineering in the development of strategies that combat life-threatening diseases,” says Faisal Ghaus, Vice President of TechNavio.

“Novel discoveries in orthopedic biomaterials have a great impact on the regenerative and repair potential of the body.”

Key Market Drivers

  • Increasing Incidence of Orthopedic Diseases among Aging Population
  • Demand for Biodegradable Products
  • Ongoing R&D in Biomaterials

Key Market Trends

  • Advances in Technology
  • Novel Discoveries

Key Market Vendors

  • Biomet Inc.
  • DePuy Synthes
  • Medtronic Inc.
  • Stryker Corp.
  • Wright Medical Group Inc.
  • Zimmer Holdings Inc.

To define the market circumstances in the next 3-4 years, analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.

If you are interested in more information on this topic and our upcoming research on the Global Orthopedic Biomaterials Market 2014-2018 ; please send an e-mail to